☆ 4.6 Article

Carbonic Anhydrase Inhibitors Induce Ferroptosis through Inhibition of AKT/FTH1 Signaling in Ewing Sarcoma Tumor Cells

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Article

Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer

Chen Zhang et al.

Oxidative Medicine and Cellular Longevity (2023)

Add to Collection

Article Oncology

Evaluating the local expression pattern of IGF-1R in tumor tissues and the circulating levels of IGF-1, IGFBP-1, and IGFBP-3 in the blood of patients with different primary bone tumors

Mohammad Amin Vaezi et al.

Summary: This study investigated the expression pattern and diagnostic significance of the IGF-1 axis main mediators in three primary bone tumor types. Elevated levels of IGF-1R gene and protein were found in bone tumors, especially in osteosarcoma and Ewing sarcoma. The circulating levels of IGF-1, IGFBP-1, and IGFBP-3 were also increased and correlated with tumor severity.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Chemistry, Multidisciplinary

Tumor-Generated Reactive Oxygen Species Storm for High-Performance Ferroptosis Therapy

Lin Huang et al.

Summary: In this study, a strategy of ROS storm generation specifically initiated by the TME and our developed nanoplatforms is proposed for high-performance ferroptosis therapy. The released TAF and CuP react with H2O2 to generate ROS and Cu+, forming a cyclic catalysis effect, resulting in a ROS storm in tumor cells for high-performance ferroptosis.

ACS NANO (2023)

Add to Collection

Article Oncology

A Carbonic Anhydrase IX/SLC1A5 Axis Regulates Glutamine Metabolism Dependent Ferroptosis in Hypoxic Tumor Cells

Geetha Venkateswaran et al.

Summary: In this study, researchers discovered that Carbonic anhydrase IX (CAIX) interacts with the glutamine (Gln) transporter, solute carrier family 1 member 5 (SLC1A5), to maintain redox homeostasis in tumor cells. Inhibiting CAIX increases Gln uptake by SLC1A5, leading to an increase in glutathione (GSH) levels. Blocking CAIX activity and Gln metabolism or the GSH/GPX4 pathway results in lipid peroxidation and induces ferroptosis in both in vitro and in vivo models. This study suggests that cotargeting CAIX and Gln metabolism could be a potential strategy to induce ferroptosis in tumor cells.

MOLECULAR CANCER THERAPEUTICS (2023)

Add to Collection

Article Oncology

Inhibition of the PI3K/AKT/mTOR signaling promotes an M1 macrophage switch by repressing the ATF3-CXCL8 axis in Ewing sarcoma

Ramona Palombo et al.

Summary: In this study, the researchers identified ATF3 as a key mediator of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells. ATF3 promotes tumor growth and metastasis by modulating the expression of chemokine-encoding genes, including CXCL8. This study provides valuable insights into the chemokine signaling in Ewing sarcoma and suggests that targeting the PI3K/AKT/mTOR pathway could promote an anti-tumoral immune response.

CANCER LETTERS (2023)

Add to Collection

Article Biology

CA9 knockdown enhanced ionizing radiation-induced ferroptosis and radiosensitivity of hypoxic glioma cells

Wenpeng Huang et al.

Summary: The study aimed to investigate whether ionizing radiation could induce ferroptosis in glioma cells and whether CA9 knockdown could enhance the killing effect of ionizing radiation on hypoxic glioma cells through ferroptosis. The results showed that X-ray could induce lipid peroxidation and ferroptosis markers expression in U251 and GL261 glioma cells. Knockdown of CA9 significantly altered the expression of iron regulation-related proteins and enhanced X-ray-induced ferroptosis and radiosensitivity in hypoxic glioma cells. Enhancing ferroptosis in glioma cells could promote the efficacy of radiotherapy for glioma.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2023)

Add to Collection

Article Biology

EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis

Sukanya Chakraborty et al.

Summary: EHD1 is overexpressed in Ewing sarcoma (EWS) and is required for metastasis and tumorigenesis by regulating cellular trafficking and plasma membrane expression of IGF-1R. Our study identifies RTK traffic regulation as a proximal mechanism of EHD1 overexpression-dependent oncogenesis in EWS, highlighting the potential of co-targeting IGF-1R and EHD1.

COMMUNICATIONS BIOLOGY (2023)

Add to Collection

Article Oncology

TIPE1 inhibits the growth of Ewing's sarcoma cells by suppressing Wnt/β-catenin signaling

Zhichao Wang et al.

Summary: This study found that TIPE1 expression is low in Ewing's sarcoma. TIPE1 inhibits the growth and survival of Ewing's sarcoma cells by suppressing cell proliferation and inducing apoptosis. It also regulates Wnt/β-catenin signaling to exert its effects.

CLINICAL & TRANSLATIONAL ONCOLOGY (2023)

Add to Collection

Article Biology

Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth

Elena Vasileva et al.

Summary: Ewing sarcoma is a malignant tumor that mainly affects children, adolescents, and young adults. The lack of a reliable genetic animal model has hindered the study of tumor cell and microenvironment interactions. By introducing human EWSR1-FLI1 gene into zebrafish, a new genetic model of Ewing sarcoma has been developed, which exhibits high penetrance and rapid tumor formation, providing a valuable tool for investigating the disease. Additionally, the study reveals the important role of the extracellular matrix in Ewing sarcoma tumor growth and suggests that targeting proteoglycan metabolism could be a potential novel therapy.

ELIFE (2022)

Add to Collection

Article Oncology

Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas

Charlotte Nazon et al.

Summary: This study correlates radiological and immunohistochemical data with the outcome in pediatric osteosarcomas (OTS) and identifies imaging and immunohistochemical markers associated with a worse overall survival. These findings suggest a potential dual signature association that can be used in future protocols to predict the outcome of OTS.

CANCERS (2022)

Add to Collection

Review Oncology

Novel Targeted Therapeutic Strategies for Ewing Sarcoma

Daria Fayzullina et al.

Summary: Ewing sarcoma is a rare malignant bone tumor with a high recurrence rate. This study identifies new therapeutic targets, particularly the EWSR1/FLI1 fusion protein, and proposes experimental therapy targeting multiple signaling pathways for improved patient survival.

CANCERS (2022)

Add to Collection

Article Oncology

Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival

Semyon Yakushov et al.

Summary: This study identified potential biomarkers of doxorubicin resistance in Ewing sarcoma cells using single-cell transcriptomic and proteomic analyses. The identified biomarkers, MGST1 and COL6A2, were found to have clinical significance for the survival of patients with Ewing sarcoma.

CANCERS (2022)

Add to Collection

Article Oncology

Hydroxygenkwanin suppresses proliferation, invasion and migration of osteosarcoma cells via the miR-320a/SOX9 axis

Xinli Dong et al.

Summary: This study investigated the therapeutic effect of Hydroxygenkwanin (HGK) on osteosarcoma and its specific molecular mechanism. The findings suggest that HGK inhibits proliferation, migration, and invasion of MG-63 and U2OS cells through the miR-320a/SOX9 axis.

MOLECULAR MEDICINE REPORTS (2022)

Add to Collection

Article Oncology

Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway

Hong-Bo Li et al.

Summary: This study demonstrates that cordycepin inhibits osteosarcoma cell growth and invasion and induces apoptosis by activating AMPK and inhibiting the AKT/mTOR signaling pathway. Furthermore, cordycepin enhances the sensitivity of osteosarcoma cells to cisplatin, suggesting its potential as a promising treatment for osteosarcoma.

CANCER CELL INTERNATIONAL (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors

Stanislav Kalinin et al.

Summary: Combination therapy is crucial for treating cancers to avoid drug resistance and tumor recurrence. The tumor microenvironment plays a significant role in drug resistance and is a viable target for therapeutic agents. Carbonic anhydrase IX inhibitors show promise in intensifying cancer chemotherapy and overcoming drug resistance in preclinical settings.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Oncology

Immunogenic ferroptosis and where to find it?

Robin Demuynck et al.

Summary: Ferroptosis is a newly discovered form of regulated cell death distinct from apoptosis and necroptosis, and has potential in anticancer therapy. However, ferroptotic cancer cells may pose a risk of tumor evasion due to decreased phagocytosis and antigen cross-presentation. Factors such as lactate, acidification, and hypoxia in the tumor microenvironment play a role in promoting ferroptosis resistance and affecting its immunogenicity.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Chemistry, Medicinal

Insertion of metal carbenes into the anilinic N-H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms

Tatiana Sharonova et al.

Summary: In this study, a set of thirty-four primary sulfonamides were synthesized and tested as inhibitors of four isoforms of human carbonic anhydrase in vitro. While many of the synthesized compounds showed promising activity against tumor-associated hCA IX and XII, they did not significantly inhibit cancer cell growth. The two compounds that exhibited antiproliferative effects were only modest hCA inhibitors, likely due to the presence of a Michael acceptor substructure.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Oncology

RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma

Elizabeth Ann Roundhill et al.

Summary: The study aimed to isolate patient-derived ES primary cell cultures and CSCs, identifying biomarkers and therapeutic targets. The results suggest neurexin-1 as a potential therapeutic target in ES, with its expression level associated with disease prognosis.

CELLULAR ONCOLOGY (2021)

Add to Collection

Article Oncology

MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases

Ilya Ulasov et al.

CANCER LETTERS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Hypoxia promotes osteosarcoma cell proliferation and migration through enhancing platelet-derived growth factor-BB/platelet-derived growth factor receptor-β axis

Dan Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Add to Collection

Article Chemistry, Medicinal

Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment

Mikhail Krasavin et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Article Chemistry, Medicinal

Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines

Mikhail Krasavin et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia

Zan Li et al.

REDOX BIOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients

Giuseppina Sannino et al.

EBIOMEDICINE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Heterocyclic periphery in the design of carbonic anhydrase inhibitors: 1,2,4-Oxadiazol-5-yl benzenesulfonamides as potent and selective inhibitors of cytosolic hCA II and membrane-bound hCA IX isoforms

Mikhail Krasavin et al.

BIOORGANIC CHEMISTRY (2018)

Add to Collection

Article Chemistry, Medicinal

Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents

Haonan Yu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Oncology

The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

Laura Forker et al.

BRITISH JOURNAL OF CANCER (2018)

Add to Collection

Article Oncology

Radiation Oncology in the Developing Economies of Central and Eastern Europe

Natia Esiashvili

SEMINARS IN RADIATION ONCOLOGY (2017)

Add to Collection

Article Oncology

Oncogenic roles of carbonic anhydrase 8 in human osteosarcoma cells

Tze-Kai Wang et al.

TUMOR BIOLOGY (2016)

Add to Collection

Article Oncology

Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome

S. Ruiz-Pinto et al.

ANNALS OF ONCOLOGY (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Structure and function of carbonic anhydrases

Claudiu T. Supuran

BIOCHEMICAL JOURNAL (2016)

Add to Collection

Article Orthopedics

Ewing's sarcoma ONLY PATIENTS WITH 100% OF NECROSIS AFTER CHEMOTHERAPY SHOULD BE CLASSIFIED AS HAVING A GOOD RESPONSE

J. I. Albergo et al.

BONE & JOINT JOURNAL (2016)

Add to Collection

Review Clinical Neurology

Acetazolamide for the treatment of idiopathic intracranial hypertension

Claudiu T. Supuran

EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)

Add to Collection

Article Oncology

Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma

Jeung Il Kim et al.

ONCOLOGY LETTERS (2015)

Add to Collection

Review Clinical Neurology

Acetazolamide for the treatment of idiopathic intracranial hypertension

Claudiu T. Supuran

EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)

Add to Collection

Article Oncology

Renal cell carcinoma with rhabdoid and sarcomatoid features presented as a metastatic thigh mass with an unusual immunohistochemical profile

Asmaa Gaber Abdou et al.

RARE TUMORS (2014)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

The role of imaging for translational research in bone tumors

Maria Serena Benassi et al.

EUROPEAN JOURNAL OF RADIOLOGY (2013)

Add to Collection

Review Biochemistry & Molecular Biology

An update on carbonic anhydrase-related proteins VIII, X and XI

Ashok Aspatwar et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)

Add to Collection

Article Pathology

Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors

Seppo Parkkila et al.

MODERN PATHOLOGY (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.